INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Mobile eTMF: Once A “Would-Be-Nice”. Now A “Must-Have”!

  The benefits of off­ering a mobile experience are simply too great to ignore.

• Scaling A Solid Tumor Study

  A mid-sized multinational biopharmaceutical company opted to internalize the study management and execution of their Phase Ib/II multicenter oncology program. As a result of positive treatment outcomes, patients continued in the trial for significantly longer than originally projected, creating a large data backlog that required source document verification. Read how strategies were deployed to obtain data currency and obtain management oversight to meet the program's expansion.

• How A Top CRO Used ClinCard To Create A Personalized Patient Experience For A Non-interventional Psoriasis Study

  The CRO realized that they needed to introduce new ways to keep participants engaged and interested if they were going to successfully support this trial. The CRO identified ClinCard as the ideal software that could instantly get study participants their stipends, without adding a burden on the site staff.

• How To Reduce Clinical Supply Expense Using An IRT System

  Mismanaging clinical supplies can threaten study outcomes, bring studies to a halt, and even jeopardize a clinical research program. This article outlines a solid clinical supply management program, defines interactive response technology (IRT) and its role in clinical supply management, and explains how implementing it can reduce risks and costs.

• Establishing Risk-Based Monitoring Within A Quality-Based System As “Best Practice” For Clinical Studies

  This report based on a survey of ACRO members reveals that Risk-Based Monitoring (RBM) makes clinical trial quality review more efficient and effective. It found that when a company reviews data through a centralized system using the RBM model, CROs and technology companies are better able to detect quality issues earlier and make rapid corrections at the site level. This type of approach is now central to ensuring the safety of patients in clinical trials, and is expected to continue to grow in importance as clinical trials becomes more numerous and complex.

• Actigraphy For Pain And Activity

  Pain is a complex medical condition that involves many physiological functions. Assessment of a patient’s sleep and activity can be critically important for understanding the full dimensions of their pain and the effect of therapies.

• Reducing Placebo Response & Measurement Error In Clinical Trials

  In this on-demand webcast, WCG experts Dr. Nathaniel Katz and Dr. Mark Opler illustrate why human error—including inaccurate symptom reporting—is driving placebo response and how proven, evidence-based interventions can be used to increase the overall chance of trial success. Hear their perspectives.

• 5 Key KPIs Every Disclosure Team Should Monitor – And Why

  Like any department within a pharmaceutical organization, clinical trial disclosure teams contribute to the bottom line and must be accountable. Here are five key performance indicators (KPIs) to monitor on a regular basis.

• First Thoughts After ISOQOL 2018

  Mark P. Wade, Executive Director, Life Sciences at TransPerfect shares his thoughts on the ISOQOL 25th Annual Conference in Dublin. Hear what professionals that live and breathe Clinical Outcome Assessment (COA) measures learned from this event.